Determining the optimal PD‐1/PD‐L1 inhibitors for the first‐line treatment of non‐small‐cell lung cancer with high‐level PD‐L1 expression in China
暂无分享,去创建一个
Yalin Dong | Yalin Dong | Yan Wang | Haisheng You | Siying Chen | Ruiying Han | Mengmeng Teng | Bo Yang | Mengna An